Patent · US Active

P2X7R antagonists and their use

US8268861B2 · kind B2 · utility

0Cited by

0References

30Claims

0Family size

Assignee

Affectis Pharmaceuticals AG · DE

Inventor

Michael Boes · Lörrach, DE

Key dates

Filing date	Feb 25, 2011
Grant date	Sep 18, 2012
Priority date	—
Expiry date	Feb 25, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application is directed to novel P2X7R antagonists that are N-indol-3-yl-acetamide and N-azaindol-3-yl-acetamide compounds, pharmaceutical compositions comprising the same and their use for the prophylactic or therapeutic treatment of diseases mediated by P2X7R activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.